Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements

WOODCLIFF LAKE, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that the Company’s unaudited financial statements for the three and six months ended June 30, 2025, are available at https://investor.eagleus.com/events-presentations.